Chris Camarra
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Chris Camarra is an Independent Director at Hoth Therapeutics, Inc. starting in 2025.
Former roles include Director at 3DX Industries, Inc. from 2021 to 2024 and Executive Vice President-Communications at TC BioPharm Ltd. Education includes undergraduate studies at West Virginia University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ROCKET ONE INC. -.--% | 26/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ROCKET ONE INC. | Director/Miembro de la Junta | 01/05/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| 3DX INDUSTRIES, INC. | Director/Miembro de la Junta | 02/01/2024 |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services | Public Communications Contact | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3DX Industries, Inc.
3DX Industries, Inc. Metal FabricationProducer Manufacturing Provides 3D metal prototyping, composite printing and precision machining services | Producer Manufacturing |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company to develop therapeutics for patients suffering from eczema | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.